Neurologix

PET Scans Show Gene Therapy Normalizes Brain Function in Parkinson's Patients

...that PET scanning can be a valuable marker in testing novel therapies for Parkinson's disease," he said. The gene therapy technique was developed by neurologix Inc., a New Jersey-based company. Scientists are now working on a design for a phase 2 blinded study that would include a larger number of patients to...

Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinson's Disease

...ed through the 12 months formal study period. neurologix sponsored the study as part of its ongoing efforts...formed the clinical evaluations and the PET scans. neurologix scientists were also co-investigators in the study...orders," said Paul Greengard, PhD, chairman of the neurologix Scientific Advisory Board and recipient of the 200...

Neurologix in Biological News

Gene therapy study shows safety and statistically significant improvement in Parkinson's disease

...ed through the 12 months formal study period. neurologix sponsored the study as part of its ongoing efforts...formed the clinical evaluations and the PET scans. neurologix scientists were also co-investigators in the study...orders,” said Paul Greengard, PhD, chairman of the neurologix Scientific Advisory Board and recipient of the 200...

Neurologix announces positive results of gene therapy clinical trial in Parkinson's disease

...d. Drs. Kaplitt and During are the co-founders of neurologix and are consultants to the company. In a joint st...aluations by mid-2006. Pending the final results, neurologix intends to formulate and submit to the FDA a pivot...stated Eric J. Nestler, M.D., Ph.D., member of the neurologix Scientific Advisory Board and Professor and Chairm...